Talimogene Laherparepvec in Advanced Mucosal Melanoma of the Urethra Upon Primary Resistance on Immune Checkpoint Inhibition: A Case Report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Talimogene Laherparepvec in Advanced Mucosal Melanoma of the Urethra Upon Primary Resistance on Immune Checkpoint Inhibition: A Case Report

Published:2020-05-08 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Fröhlich Anne,Hoffmann Friederike,Niebel Dennis,Egger Eva,Kukuk Guido M.,Toma Marieta,Sirokay Judith,Bieber Thomas,Landsberg Jennifer

Funder

Deutsche Forschungsgemeinschaft

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference27 articles.

1. Primary malignant melanoma of the female urethral meatus;Robutti;Eur Urol.,1986

2. Management of primary melanoma of the female urogenital tract;Piura;Lancet Oncol.,2008

3. Whole-genome landscapes of major melanoma subtypes;Hayward;Nature,2017

4. Response to imatinib in vaginal melanoma with KIT p.Val559Gly mutation previously treated with nivolumab, pembrolizumab and ipilimumab;Komatsu-Fujii;J Dermatol.,2019

5. Melanoma subtypes demonstrate distinct PD-L1 expression profiles;Kaunitz;Lab Investig J Tech Methods Pathol.,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Local intralesional talimogene laherparepvec therapy with complete local response in oral palatine mucosal melanoma: a case report;Journal of Medical Case Reports;2024-05-23

2. Primary malignant melanoma of the female urethra A rare histopathology case report;Urology Case Reports;2024-01

3. Immunotherapy for mucosal melanoma;Oncology and Translational Medicine;2023-12

4. Identification of distinct genomic features reveals frequent somatic AHNAK and PTEN mutations predominantly in primary malignant melanoma presenting in the ureter;Japanese Journal of Clinical Oncology;2022-05-16

5. Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model;Pharmaceutics;2021-04-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3